Robert F. Kennedy Jr., now leading the U.S. Department of Health and Human Services, stands accused of secretly using psychedelics despite his long claim of sobriety. A new book by journalist Olivia Nuzzi drops this bombshell, hinting at a hidden side to the health chief’s life amid his push for drug reforms. What does this mean for his role in shaping America’s health policies?
A forthcoming memoir by Olivia Nuzzi, titled “American Canto,” has sparked major buzz with its claims about RFK Jr.’s personal habits. The book suggests that Kennedy, who has publicly celebrated his decades of sobriety after battling heroin addiction, still turns to psychedelics.
Nuzzi alleges that RFK Jr. admitted to smoking dimethyltryptamine, or DMT, a potent hallucinogen known for triggering intense, near-death-like experiences. This detail comes from their alleged romantic relationship, which Nuzzi describes in vivid terms.
The revelations have rippled through media circles. Published reports indicate the book implies Kennedy makes an exception for these substances while staying sober from other drugs. Nuzzi, a former New York Magazine writer, didn’t hold back on intimate details, including conversations where Kennedy shared his ongoing use.
This isn’t just gossip. It ties into Kennedy’s public persona as a health advocate who overcame addiction.
Recent news coverage highlights how the book portrays their interactions as deeply personal, with Kennedy reportedly discussing his psychedelic experiences openly with her.
RFK Jr.’s Long Battle with Addiction
Kennedy’s history with drugs is no secret. He has spoken candidly about his struggles, including a 14-year heroin addiction that started in his teens.
He got sober in 1983 after a felony drug possession arrest, and since then, he’s built a reputation as an anti-addiction crusader. As a presidential candidate in 2024, he often shared his story to connect with voters facing similar issues.
But these new claims challenge that narrative. If true, they suggest Kennedy views psychedelics differently, perhaps as tools for healing rather than harmful vices.
His family legacy adds layers. As a nephew of President John F. Kennedy and son of Senator Robert F. Kennedy, he’s no stranger to public scrutiny.
In interviews, Kennedy has described hitting rock bottom before turning his life around. That turnaround led him to environmental law and now, a top government post.
Pushing for Psychedelic Therapies in Office
Kennedy hasn’t shied away from praising psychedelics for their potential benefits. As HHS Secretary under President Donald Trump, he’s advocated for their use in treating mental health issues like depression and PTSD.
He has called for faster approval of psychedelic therapies, aiming to get them available within a year. This stance comes after the FDA rejected a psychedelic-assisted treatment for PTSD in 2024.
At a recent “Make America Healthy Again” summit, Kennedy joined other officials in sessions exploring these drugs’ therapeutic roles. He’s pushed to deschedule substances like ibogaine, arguing they hold real healing power.
His views stem from personal insights. Kennedy has said people should have the freedom to try hallucinogens for tough disorders.
Colorado’s governor reportedly discussed advancing psychedelic programs with him, showing Kennedy’s commitment to this cause.
Yet, the book’s allegations raise questions. Does his alleged personal use influence his policies?
Supporters see it as authentic passion. Critics worry about conflicts in a role overseeing drug regulations.
Here are key psychedelics Kennedy has backed:
- Psilocybin for depression treatment
- MDMA for PTSD therapy
- Ibogaine for addiction recovery
These align with growing research, like a 2023 study from Johns Hopkins University showing psilocybin’s promise in easing severe depression symptoms.
Broader Impact on Public Health and Politics
These claims could shake trust in Kennedy’s leadership at HHS. As the agency handles everything from drug approvals to addiction programs, any hint of hypocrisy might fuel backlash.
Politicians and health experts are watching closely. Some praise his bold ideas on mental health, while others question if personal habits cloud his judgment.
A 2025 report from the Substance Abuse and Mental Health Services Administration notes rising interest in alternative therapies amid America’s opioid crisis.
Kennedy’s team hasn’t directly addressed the book’s specifics, but he’s continued promoting recovery through community and nature-based approaches.
This scandal touches on bigger debates. With mental health cases up 20 percent since 2020, per CDC data, innovative treatments like psychedelics could help millions.
But transparency matters in public office. If proven, these allegations might prompt calls for clearer guidelines on officials’ drug use.
The story also highlights shifting views on substances. Once taboo, psychedelics now gain traction in states like Oregon, where psilocybin therapy became legal in 2023.
| Year | Key Event in RFK Jr.’s Drug-Related Journey |
|---|---|
| 1983 | Achieves sobriety after heroin addiction |
| 2023 | Advocates for psychedelic research as candidate |
| 2025 | Appointed HHS Secretary, pushes therapies |
| 2025 | Book alleges ongoing psychedelic use |
This timeline shows the contrast between his public image and the new claims.
The revelations about RFK Jr. using psychedelics while claiming sobriety hit at a time when America grapples with addiction and mental health crises, leaving many to wonder if his personal choices strengthen or undermine his push for change. It sparks hope for innovative treatments but also stirs outrage over potential double standards in high places.
